Clinical trial
An Open-label Study of Etanercept (Enbrel) Efficacy in Ankylosing Spondylitis
NCT01289743 is registered in ClinicalTrials.gov with Charite University, Berlin, Germany as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open-label Study of Etanercept (Enbrel) Efficacy in Ankylosing Spondylitis
- Lead sponsor
- Charite University, Berlin, Germany
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- February 28, 2002
- Completion date
- May 31, 2012
- Enrollment
- 24 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
ankylosing spondylitis